Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2008 | 1 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Recurrent or Refractory High-Grade Gliomas Treated by Convection-Enhanced Delivery of a TGFβ2-Targeting RNA Therapeutic: A Post-Hoc Analysis with Long-Term Follow-Up.
Cancers (Basel). 2019 Nov 28;11(12):1892. doi: 10.3390/cancers11121892.
Cancers (Basel). 2019.
PMID: 31795071
Free PMC article.
Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer.
D'Cruz OJ, Qazi S, Hwang L, Ng K, Trieu V.
D'Cruz OJ, et al. Among authors: hwang l.
Onco Targets Ther. 2018 May 14;11:2779-2796. doi: 10.2147/OTT.S161905. eCollection 2018.
Onco Targets Ther. 2018.
PMID: 29785126
Free PMC article.
Item in Clipboard
Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status.
Desai NP, Trieu V, Hwang LY, Wu R, Soon-Shiong P, Gradishar WJ.
Desai NP, et al. Among authors: hwang ly.
Anticancer Drugs. 2008 Oct;19(9):899-909. doi: 10.1097/CAD.0b013e32830f9046.
Anticancer Drugs. 2008.
PMID: 18766004
Item in Clipboard
Cite
Cite